CYP24A1 and breast carcinoma: Analysis of malignant and benign breast tumors obtained from patients after surgery has demonstrated CYP24A1 splicing in breast cancer, and the expression of CYP24A1 protein is significantly reduced in cancerous tissue compared to benign tissue19.